Jefferies Group LLC Sellas Life Sciences Group, Inc. Transaction History

Jefferies Group LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$8.21 - $10.53 $1.23 Million - $1.58 Million	-150,000 Closed	0 $0
Q2 2021 Sep 21, 2023	BUY	$7.19 - $13.71 $945,485 - $1.8 Million	131,500 Added 710.81%	150,000 $1.67 Million
Q2 2021 Aug 16, 2021	BUY	$7.19 - $13.71 $945,485 - $1.8 Million	131,500 Added 710.81%	150,000 $1.67 Million
Q1 2021 Sep 21, 2023	BUY	$5.5 - $11.71 $101,750 - $216,635	18,500 New	18,500 $157,000
Q1 2021 May 14, 2021	BUY	$5.5 - $11.71 $101,750 - $216,635	18,500 New	18,500 $158,000

8.03M

2.52M

24.7K

Ticker SLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,551,900
Market Cap $23M
Description
SELLAS Life Sciences Group, Inc., a late-stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States. Its lead product candidate is galinpepimut-S (GPS), a cancer immunotherapeutic agent that targets Wilms tumor 1, which is in Phase III clinical trials for the tr...

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

Stay updated on Jefferies Group LLC with notifications on news.